Related Experiment Video
Updated: May 7, 2026
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
The Application of the Plan-Do-Check-Act Management Model in Improving the Diagnostic Yield of Autoimmune Gastritis
Yixin Zhu1,2, Shisong Wang1, Qian Yu3
1Health Science Center, Ningbo University, 818 Fenghua Rd, Ningbo, 315211, Zhejiang Province, China.
Background:
Due to the lack of unified diagnostic standards and low clinical awareness, autoimmune gastritis (AIG) remains underdiagnosed globally. This study aimed to employ the Plan-Do-Check-Act (PDCA) cycle to enhance the diagnostic rate of AIG.
Methods:
This single-center, prospective, observational study enrolled 20 endoscopists from two hospital campuses (10 each in the intervention and control groups). The intervention group underwent PDCA cycle management, including standardized training and dynamic data monitoring, while the control group received no intervention. Diagnostic rates were compared before and after the intervention.
Results:
A total of 9,763 patients underwent gastroscopy by 20 endoscopists, among whom 67 were diagnosed with AIG. Application of the PDCA cycle further standardized the diagnostic process of AIG in the Department of Gastroenterology at the First Affiliated Hospital of Ningbo University. The diagnostic rate of AIG in the PDCA group reached 0.987%, while that in the control group was 0.423% (P < 0.001), exceeding the target of 0.9% and higher than previously reported baseline rates in Asia. Moreover, the diagnostic rates at all stages of the PDCA cycle in the PDCA group were higher than those in the control group.
Conclusion:
Implementation of the PDCA cycle was associated with a higher diagnostic rate of AIG in this quality-improvement setting, supporting its potential value in improving case detection and standardizing the diagnostic workflow. Trial registration Clinical Trials.gov,NCT06557252. Registered on 13/8/2024. https://register.
Clinicaltrials:
gov/prs/beta/studies/S000ESP900000038/recordSummary . Registered 6 July 2021.
Related Concept Videos
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:27Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...